IC 202A
Alternative Names: Immunosuppressant-siderophoreLatest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 15 Mar 1999 New profile
- 15 Mar 1999 Preclinical development for Cancer in Japan (Unknown route)